Systemic Sclerosis

Systemic Sclerosis-Associated PAH Genomic Signature Differs From ILD

Systemic Sclerosis-Associated PAH Genomic Signature Differs From ILD

By

Systemic sclerosis-associated pulmonary hypertension and systemic sclerosis-associated interstitial lung disease exhibit similar but distinct gene expression profiles.

Severe Gastrointestinal Disease in Early Systemic Sclerosis Linked to Increased Morbidity, Mortality

Severe Gastrointestinal Disease in Early Systemic Sclerosis Linked to Increased Morbidity, Mortality

By

Severe gastrointestinal disease is common in early systemic sclerosis, and is linked to increased mortality.

Increased Prevalence of Systemic Sclerosis Observed in the United Kingdom

Increased Prevalence of Systemic Sclerosis Observed in the United Kingdom

By

Researchers estimated the incidence and prevalence of systemic sclerosis in recent years in the United Kingdom.

Exercise Oxygen Desaturation, Pulmonary Function Predict Outcomes in SSc-PH

Exercise Oxygen Desaturation, Pulmonary Function Predict Outcomes in SSc-PH

By

Factors associated with a higher risk for mortality included male sex, exercise desaturation, and diffusing capacity of the lungs for carbon monoxide <50%.

Short-Term Progression of Interstitial Lung Disease in Systemic Sclerosis Predictive of Long-Term Survival

Short-Term Progression of Interstitial Lung Disease in Systemic Sclerosis Predictive of Long-Term Survival

By

A decline in FVC and DLCO over 2 years was a better predictor of mortality than baseline FVC and DLCO.

High-Resolution CT Useful in Systemic Sclerosis-Associated ILD Screening

High-Resolution CT Useful in Systemic Sclerosis-Associated ILD Screening

By

Clinicians should incorporate chest high-resolution computed tomography when screening patients with systemic sclerosis-associated interstitial lung disease even when pulmonary function tests results are normal.

Depression Prevalent Among Individuals With Systemic Sclerosis

Depression Prevalent Among Individuals With Systemic Sclerosis

By

Depression is prevalent in a considerable proportion of patients with systemic sclerosis.

Statin Initiation Reduces Overall Mortality in Systemic Autoimmune Rheumatic Diseases

Statin Initiation Reduces Overall Mortality in Systemic Autoimmune Rheumatic Diseases

By

The initiation of statin therapy is associated with reduced overall mortality in patients with systemic autoimmune rheumatic diseases.

Ultrasonographic Synovial Involvement Frequent in Systemic Sclerosis

Ultrasonographic Synovial Involvement Frequent in Systemic Sclerosis

By

Ultrasonographic synovial involvement is frequent in patients with systemic sclerosis.

Older Age Associated With Greater Cardiac Involvement in Early Systemic Sclerosis

Older Age Associated With Greater Cardiac Involvement in Early Systemic Sclerosis

By

In patients in the early stages of systemic sclerosis, older patients had more severe disease with greater cardiac involvement.

Risk Factors for Scleroderma Renal Crisis in Systemic Sclerosis

Risk Factors for Scleroderma Renal Crisis in Systemic Sclerosis

By

Researchers identify risk factors for scleroderma renal crisis in patients with systemic sclerosis.

Strong Reproducibility for 6-Minute Walk Test in Systemic Sclerosis

Strong Reproducibility for 6-Minute Walk Test in Systemic Sclerosis

By

Investigators assessed the reproducibility and the utility of the 6-minute walk test in systemic sclerosis.

Little Data Available for Small Intestinal Bacterial Overgrowth Treatment in Systemic Sclerosis

Little Data Available for Small Intestinal Bacterial Overgrowth Treatment in Systemic Sclerosis

By

For some patients with systemic sclerosis, antibiotics can eradicate small intestinal bacterial overgrowth.

SPAR Model May Predict Mild Interstitial Lung Disease in Systemic Sclerosis

SPAR Model May Predict Mild Interstitial Lung Disease in Systemic Sclerosis

By

The SPAR prediction model might be helpful for the risk stratification of mild ILD in patients with SSc in clinical practice.

PAH in Systemic Sclerosis Increases Risk for Early Mortality

PAH in Systemic Sclerosis Increases Risk for Early Mortality

By

The majority of deaths in patients with systemic sclerosis-associated pulmonary arterial hypertension occurred within 4 years of diagnosis.

Sildenafil, Bosentan Combination vs Sildenafil Monotherapy in SSc-Associated PAH

Sildenafil, Bosentan Combination vs Sildenafil Monotherapy in SSc-Associated PAH

By

There was no significant difference in efficacy between sildenafil and bosentan initial combination therapy and sildenafil monotherapy in patients with systemic sclerosis-related pulmonary arterial hypertension.

Smoking Not Associated With Systemic Sclerosis-Specific Cutaneous, Pulmonary Manifestations

Smoking Not Associated With Systemic Sclerosis-Specific Cutaneous, Pulmonary Manifestations

By

Smoking status in patients with systemic sclerosis was not significantly associated with systemic sclerosis-specific cutaneous or pulmonary changes.

PAH-Associated Connective Tissue Diseases: A Case for Separating SSc, SLE

PAH-Associated Connective Tissue Diseases: A Case for Separating SSc, SLE

By

Recent evidence suggests that systemic sclerosis and SLE in pulmonary arterial hypertension should be considered separate diseases.

LPA1 Receptor Antagonist SAR100842 Safe, Well Tolerated in Systemic Sclerosis

LPA1 Receptor Antagonist SAR100842 Safe, Well Tolerated in Systemic Sclerosis

By

The investigational drug SAR100842 was safe, moderately effective, and well tolerated in patients with early diffuse cutaneous systemic sclerosis.

Expert Insight: Detecting Pulmonary Arterial Hypertension in Patients With Systemic Sclerosis

Expert Insight: Detecting Pulmonary Arterial Hypertension in Patients With Systemic Sclerosis

By

Although pulmonary arterial hypertension occurs in a minority of patients with systemic sclerosis, clinicians must be attentive to it, as it can emerge at any point over the course of the disease.

Independent Predictors of VTE Identified in Systemic Sclerosis

Independent Predictors of VTE Identified in Systemic Sclerosis

By

Researchers evaluated the prevalence, risk factors, and effect of venous thromboembolism on survival in systemic sclerosis.

Predicting Skin Score Changes in Early Diffuse Systemic Sclerosis

Predicting Skin Score Changes in Early Diffuse Systemic Sclerosis

By

Two predictive models for progressive skin thickening in patients with early diffuse cutaneous systemic sclerosis were developed to use in clinical practice and to improve recruitment in clinical trials.

Stem Cell Transplant May Benefit Patients With Systemic Sclerosis

Stem Cell Transplant May Benefit Patients With Systemic Sclerosis

Patients who underwent autologous hematopoietic stem cell transplant for systemic sclerosis saw improvements in quality of life.

PAH Incidence in Systemic Sclerosis: Does Algorithm Use Affect Reported Incidence?

PAH Incidence in Systemic Sclerosis: Does Algorithm Use Affect Reported Incidence?

By

Use of the DETECT algorithm did not change incidence of PAH, but led to an increased frequency of cases of borderline pulmonary hypertension.

Patients With Early SSc-PAH Development Have Substantial Rate of Disease Progression

Patients With Early SSc-PAH Development Have Substantial Rate of Disease Progression

By

Patients with systemic sclerosis and early-diagnosed pulmonary arterial hypertension had disease progression over a relatively short period of time.

Predicting Mortality in Systemic Sclerosis-PAH With CT Signs of Veno-Occlusive Disease

Predicting Mortality in Systemic Sclerosis-PAH With CT Signs of Veno-Occlusive Disease

By

A blinded analysis sought to determine whether CT signs of pulmonary veno-occlusive disease are common and predictive of mortality in patients with systemic sclerosis and pulmonary arterial hypertension.

Key Hemodynamic Differences Noted With Scleroderma-Associated PAH vs Idiopathic PAH

Key Hemodynamic Differences Noted With Scleroderma-Associated PAH vs Idiopathic PAH

By

Patients with systemic sclerosis-associated pulmonary arterial hypertension display important differences in hemodynamic and pulmonary function parameters compared with patients with idiopathic PAH.

Non-Adjuvanted Influenza A H1N1 Vaccine Safe, Efficacious in Patients With Systemic Sclerosis

Non-Adjuvanted Influenza A H1N1 Vaccine Safe, Efficacious in Patients With Systemic Sclerosis

By

Use of the non-adjuvanted influenza A H1N1 vaccine was shown to be safe and efficacious in patients with systemic sclerosis.

Rheumatoid Arthritis, Systemic Sclerosis Patients Should Have Hand Function Evaluated

Rheumatoid Arthritis, Systemic Sclerosis Patients Should Have Hand Function Evaluated

By

Study evaluated hand function and potential influence of functional loss on patients' overall physical functions, health-related quality of life, and psychological status in patients with rheumatoid arthritis and systemic sclerosis.

Systematic Sclerosis Ulcers Benefit from Hyperbaric Oxygen Treatment

Systematic Sclerosis Ulcers Benefit from Hyperbaric Oxygen Treatment

By

Hyperbaric oxygen therapy completely healed 4 patient's systemic sclerosis ulcers.

Sign Up for Free e-newsletters